Biosimilars and Bone Health - Episode 2
Jeffrey Curtis, MD, MS, MPH, provides expert perspective for navigating the evolving treatment landscape of osteoporosis and key considerations for biologic and biosimilar utilization.
*Content was developed independently by The Center for Biosimilars® and supported by Sandoz.